Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Disease area: Airway diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
H. Oliveira (Rio de Janeiro, Brazil), C. Batista (Rio de Janeiro, Brazil), M. Lima (Rio de Janeiro, Brazil), E. Amorim (Rio de Janeiro, Brazil), A. Silva (Rio de Janeiro, Brazil), T. Maron-Gutierrez (Rio de Janeiro, Brazil), H. Castro-Faria-Neto (Rio de Janeiro, Brazil). Effects of ASA and DHA therapy on malaria associated ARDS. 4291

Member's Comments

No comment yet.

Related content which might interest you: The effect of conjugated linoleic acid supplementation on the nutritional status of COPD patients Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Effect of antibiotic prophylaxis on pneumonia in cardiac arrest patients treated with therapeutic hypothermia Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Effects of high dose N-acetylcysteine in COPD patients Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Cardiovascular effects of high dose N-acetylcysteine in severe pneumonia-induced sepsis Source: Eur Respir J 2003; 22: Suppl. 45, 452s Year: 2003 LSC Abstract – Effects of vitamin D supplementation on perioperative markers of inflammation in patients at risk of acute respiratory distress syndrome (ARDS) Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Effect of daily azithromycin therapy and adherence on readmission risk in COPD Source: Eur Respir J, 53 (3) 1801377; 10.1183/13993003.01377-2018 Year: 2019 Efficacy of surfactant-BL in treatment ARDS in patients with severe inhalation injury Source: Eur Respir J 2006; 28: Suppl. 50, 345s Year: 2006 Exogenous surfactant administration in patients at high risk to develop ARDS after multiple trauma Source: Eur Respir J 2001; 18: Suppl. 33, 7s Year: 2001 Effect of 2-Year therapy with Roflumilast in severe systemic inflammation in COPD with metabolic syndrome Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Tiotropium reduces oral prednisone requirements while improving respiratory function in patients with severe persistent asthma Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Effect of azithromycin treatment on inflammation in COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005 Effect of roflumilast on exacerbations in patients with severe COPD and a prior history of hospitalization taking combination therapy Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 Influence of inhaled bronchodilator therapy on bacterioexcretion and LQ in patients with pulmonary TB infection with concomitant broncho-obstructive syndrome Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Effect of low dose theophylline as adjunct in treatment of COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Increased platelet reactivity during acute exacerbations of COPD, irrespective of antiplatelet therapy Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Effect of erdosteine in moderately severe COPD patients Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 High doses of N-acetylcysteine alone or in combination with inhaled corticosteroids and oxidative stress in patients with COPD Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Low risk of adrenal dysfunction in children with severe asthma treated with high-dose inhaled glucocorticoids Source: Eur Respir J 2005; 26: Suppl. 49, 161s Year: 2005